Back to search
Non-colorectal Liver Metastasis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-colorectal Liver Metastasis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-colorectal Liver Metastasis trials you may qualify forPatients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despite…
To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.
Patients with refractory metastatic colorectal cancer or non-small cell lung cancer with liver metastasis treated with Trans-arterial Tirapazamine Embolization…
This study is an open-label Phase Ib (Part A) dose escalation followed by a blinded, randomized, multi cohort Phase 2a (Part B) comparison of combination vs. re…
This study is being done to collect tissue samples to test how accurately a tumor response platform, Elephas, can predict clinical response across multiple type…
This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary…
The primary objective of this study, sponsored by Travera Inc. in Massachusetts, is to validate whether the mass response biomarker has potential to predict res…
This is a single-arm pilot feasibility study evaluating the combination of Botensilimab and Balstilimab with Radiation Therapy (RT) in Non-Microsatellite Instab…
This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profiles of a nove…